Current Protocol
Loading...
Injection History
Loading...
💉 Log an Injection
➕ Add / Edit Peptide
📝 New Daily Entry
Loading...
Lipid Panel
In Range
High
Low
✅ Trending Better
❌ Trending Worse
➡️ Stable
| Marker | Reference | Sep 17, 2025 | May 28, 2026 | Trend | Notes |
|---|---|---|---|---|---|
| Total Cholesterol mg/dL | <200 | 216 ↑ | 186 | ✅ ↓30 | Dropped into desirable range |
| HDL mg/dL | ≥40 | 45 | 37 ↓ | ❌ ↓8 | Now below threshold — needs attention |
| LDL mg/dL | <100 | 146 ↑ | 127 ↑ | ✅ ↓19 | Improving but still elevated |
| Triglycerides mg/dL | <150 | 130 | 111 | ✅ ↓19 | Good improvement |
| Chol / HDL Ratio | <5.0 | 4.8 | 5.0 ↑ | ❌ ↑0.2 | HDL drop is the driver |
| Non-HDL Cholesterol mg/dL | <130 | 171 ↑ | — | — | Calculated today: 186−37=149 (still elevated) |
| LDL / HDL Ratio | <2.28 = low risk | 3.2 | 3.4 | ❌ ↑0.2 | Average risk range |
Metabolic Health
⚠️ Glucose context: Sep 2025 glucose (106) was fasting. May 2026 glucose (91) was random (non-fasting) — not directly comparable. A1C is the better longitudinal marker.
| Marker | Reference | Sep 17, 2025 | May 28, 2026 | Trend | Notes |
|---|---|---|---|---|---|
| Hemoglobin A1C % | <5.7 | 6.1 ↑ | 5.8 ↑ | ✅ ↓0.3 | Improving — still prediabetic range |
| Glucose mg/dL | 65–99 fasting | 106 ↑ fasting | 91 random | ➡️ | Not directly comparable |
| Insulin uIU/mL | ≤18.4 | 20.4 ↑ | ⚠️ Tap to add | — | Was elevated — retest recommended |
| hs-CRP mg/L | <1.0 optimal | 2.1 | ⚠️ Tap to add | — | Average CV risk — retest recommended |
Comprehensive Metabolic Panel
| Marker | Reference | Sep 17, 2025 | May 28, 2026 | Trend | Notes |
|---|---|---|---|---|---|
| Kidney Function | |||||
| eGFR mL/min/1.73m² | ≥60 | 120 | 99 | ➡️ | Both excellent; different equations used |
| Creatinine mg/dL | 0.60–1.30 | 0.67 | 0.97 | ➡️ | Both in range; worth monitoring |
| BUN mg/dL | 7–25 | 11 | 21 | ➡️ | Both in range |
| Electrolytes | |||||
| Sodium mmol/L | 135–146 | 138 | 139 | ➡️ | Stable |
| Potassium mmol/L | 3.5–5.3 | 4.7 | 4.4 | ➡️ | Stable |
| Chloride mmol/L | 98–110 | 100 | 101 | ➡️ | Stable |
| CO₂ mmol/L | 20–32 | 30 | 29 | ➡️ | Stable |
| Calcium mg/dL | 8.6–10.3 | 9.7 | 9.5 | ➡️ | Stable |
| Liver / Protein | |||||
| ALT U/L | 9–46 / 7–52 | 29 | 16 | ✅ ↓13 | Improved significantly |
| AST U/L | 10–40 / 13–39 | 19 | 14 | ✅ ↓5 | Improved |
| Alkaline Phosphatase U/L | 36–130 | 86 | 74 | ✅ ↓12 | Improved |
| Albumin g/dL | 3.6–5.1 | 4.5 | 4.7 | ✅ ↑0.2 | Good |
| Total Protein g/dL | 6.1–8.1 | 7.2 | 7.5 | ✅ ↑0.3 | Good |
Complete Blood Count
✅ Notable improvement: MCH and MCHC were both flagged low in September and are now in range.
| Marker | Reference | Sep 17, 2025 | May 28, 2026 | Trend | Notes |
|---|---|---|---|---|---|
| Red Blood Cells | |||||
| WBC K/uL | 3.6–11.2 | 6.7 | 5.3 | ✅ ↓1.4 | Healthy |
| RBC M/uL | 4.06–5.63 | 5.58 | 5.49 | ➡️ | Stable |
| Hemoglobin g/dL | 12.5–17.1 | 14.8 | 14.6 | ➡️ | Stable |
| Hematocrit % | 37–50 | 47.3 | 45.0 | ➡️ | Stable |
| MCV fL | 74–100 | 84.8 | 81.0 | ➡️ | Stable |
| MCH pg | 24–33 | 26.5 ↓ | 27.0 | ✅ Back in range | Was flagged low — normalized |
| MCHC g/dL | 33–36 | 31.3 ↓ | 33.0 | ✅ Back in range | Was flagged low — normalized |
| RDW % | 11–17 | 13.1 | 13.4 | ➡️ | Stable |
| Platelets | |||||
| Platelet Count K/uL | 140–450 | 395 | 325 | ✅ ↓70 | Both in range |
| MPV fL | 7.5–12.5 | 9.9 | 8.9 | ➡️ | Stable |
| Differential | |||||
| Neutrophils % | 43–77 | 50.4 | 46 | ➡️ | Stable |
| Lymphocytes % | 16–44 | 38.3 | 42 | ➡️ | Stable |
| Monocytes % | 5–13 | 8.8 | 9 | ➡️ | Stable |
Hormones & Thyroid
⚠️ Testosterone continues to decline. Total dropped 204 → 163 ng/dL — well below clinical threshold. Free and bioavailable were not retested but were also low in September. Urgent follow-up warranted.
| Marker | Reference | Sep 17, 2025 | May 28, 2026 | Trend | Notes |
|---|---|---|---|---|---|
| Testosterone | |||||
| Total Testosterone ng/dL | 198–679 | 204 ↓ | 163 ↓ | ❌ ↓41 | Declining — well below normal range |
| Free Testosterone pg/mL | 46–224 | 42.1 ↓ | ⚠️ Tap to add | — | Was low |
| Bioavailable T ng/dL | 110–575 | 86.5 ↓ | ⚠️ Tap to add | — | Was low |
| SHBG nmol/L | 10–50 | 16 | ⚠️ Tap to add | — | Was in range |
| Estradiol pg/mL | ≤39 | 31 | ⚠️ Tap to add | — | Was in range |
| DHEA Sulfate mcg/dL | 61–442 | 173 | ⚠️ Tap to add | — | Was in range |
| Cortisol mcg/dL | 4.0–22.0 AM | 7.5 | ⚠️ Tap to add | — | Was in range (lower end) |
| Thyroid | |||||
| TSH mIU/L | 0.40–4.50 | 1.68 | 2.9 | ➡️ | Both in range |
| Free T4 ng/dL | 0.8–1.8 | 1.6 | ⚠️ Tap to add | — | Was in range |
| Free T3 pg/mL | 2.3–4.2 | 3.9 | ⚠️ Tap to add | — | Was in range |
| Prostate | |||||
| PSA ng/mL | ≤4.00 | 0.25 | 0.32 | ➡️ | Both well within range |
Vitamins, Minerals & Iron
⚠️ Vitamin D continues to decline — 28 → 24 ng/mL, approaching deficiency. Supplement urgently.
| Marker | Reference | Sep 17, 2025 | May 28, 2026 | Trend | Notes |
|---|---|---|---|---|---|
| Vitamins | |||||
| Vitamin D 25-OH ng/mL | 30–100 | 28 ↓ | 24 ↓ | ❌ ↓4 | Approaching deficiency — supplement urgently |
| Vitamin B12 pg/mL | 180–914 | 298 | 265 | ❌ ↓33 | Declining; lower zone has occult deficiency risk |
| Folate ng/mL | >5.4 | 7.3 | ⚠️ Tap to add | — | Was normal |
| Minerals | |||||
| Magnesium mg/dL | 1.5–2.5 | 2.0 | 2.1 | ✅ ↑0.1 | Stable and in range |
| Iron (new May 2026) | |||||
| Iron ug/dL | 50–212 | — | 87 | — | Baseline established |
| Ferritin ng/mL | 24–336 | 109 | 143 | ✅ ↑34 | Both in range; increase is positive |
| TIBC ug/dL | 250–425 | — | 431 ↑ | — | Slightly elevated; can indicate lower iron stores |
| % Iron Saturation | 16–43% | — | 20% | — | In range |
DEXA Body Composition — Baseline May 22, 2026
📐 Baseline scan. All future DEXA results will compare against these numbers. DXA Body Composition NC, Durham · Height 71 in · Weight 250.4 lbs · Age 43.4
Total Body Fat %
41.6%
95th centile vs. peers
Fat Mass
100.7 lbs
Target: reduce
Lean Mass
141.4 lbs
67th centile — maintain/increase
BMD (Total)
1.358 g/cm²
80th centile · Z-score +0.9 ✅
Android Fat %
53.5%
Visceral/belly fat — high risk
Visceral Fat (VAT)
7.36 lbs
215.84 in³ — metabolic risk
BMI
34.9
Obese range (WHO)
RSMI (Muscle Index)
9.25 kg/m²
75th centile — good muscle mass
Est. Resting Metabolic Rate
1,744 cal/day
Mifflin-St Jeor
Segmental Breakdown
| Region | % Fat | Total (lbs) | Fat (lbs) | Lean (lbs) | BMC (lbs) |
|---|---|---|---|---|---|
| Arms | 37.7% | 30.4 | 11.0 | 18.3 | 1.1 |
| Legs | 33.0% | 74.7 | 23.7 | 48.1 | 3.0 |
| Trunk | 48.9% | 130.9 | 62.9 | 65.8 | 2.2 |
| Android (belly) | 53.5% | 21.6 | 11.5 | 10.0 | 0.1 |
| Gynoid (hips) | 37.4% | 36.3 | 13.3 | 22.2 | 0.8 |
| TOTAL | 41.6% | 249.6 | 100.7 | 141.4 | 7.5 |